Why Moderna Tanked, MSG Employees Duped By Their Boss, The Mansion Section | Diet TBPN

Moderna's cancer-vaccine Phase III data came in below hype (42% vs 49% expected), and an embargo leak triggered an 18-26% stock plunge.

• Moderna's leak fiasco: Phase III results for Moderna's personalized cancer vaccine (with Merck's Keytruda) showed a 42% relative risk reduction versus a hoped-for 49%, and embargoed data leaked via Oncology Central two days early, sending shares down 18-26%.
• Meme trader's lucky flip: Gambling influencer Togi flipped Moderna calls to puts just before the crash, turning panic-driven position changes into a documented 'giga stroke of luck' on X.

Themes, sentiment and reasons are AI-written paraphrases, checked so they never quote an episode. They may contain errors. Not investment advice. Episodes remain the property of their creators.